Results 21 to 30 of about 108,742 (282)

bel-enrichment/bel-enrichment v0.0.3

open access: yes, 2019
A package for generating curation sheets for rationally enriching a BEL graph using INDRA and ...
Daniel Domingo-Fernández   +1 more
core   +1 more source

First Application of a Mixed Porcine–Human Repopulated Bioengineered Liver in a Preclinical Model of Post-Resection Liver Failure

open access: yesBiomedicines
In this study, a mixed porcine–human bioengineered liver (MPH-BEL) was used in a preclinical setup of extracorporeal liver support devices as a treatment for a model of post-resection liver failure (PRLF).
Philipp Felgendreff   +15 more
doaj   +1 more source

Implementing an occupational therapy specific mental health intervention in a multi-professional context – the case of Balancing Everyday Life (BEL)

open access: yesScandinavian Journal of Occupational Therapy, 2021
Background The occupation-based intervention Balancing Everyday Life (BEL) was found effective under controlled conditions but should also be studied in a natural clinical practice context.
Mona Eklund, Elisabeth Argentzell
doaj   +1 more source

Xiaochaihu decoction induces Bel-7402/5-FU cell apoptosis and autophagy via PI3K/AKT/mTOR pathway

open access: yesJournal of Holistic Integrative Pharmacy, 2023
Objective: This study aimed to observe the inhibitory effects of xiaochaihu decoction (XCHD) on human hepatocellular carcinoma (HCC) cells resistant to 5-fluorouracil (5-FU) (Bel-7402/5-FU) in vitro and in vivo and investigate its possible mechanisms ...
Xuejun Zhang   +5 more
doaj   +1 more source

Implementasi Cron Job Linux Sebagai Bel Pergantian Kelas Otomatis Di Universitas Klabat

open access: yesCogito Smart Journal, 2018
Proses pembelajaran dan proses pergantian kelas di Universitas Klabat semuanya diatur oleh bel. Proses manual masih digunakan untuk membunyikan bel yang terbuat dari lempengan besi.
Jimmy Moedjahedy
doaj   +1 more source

cthoyt/bel-repository v0.0.4

open access: yes, 2019
A utility for loading data from repositories of BEL ...
Charles Tapley Hoyt
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

BEL OKULLARI

open access: yesThe Turkish Journal of Gastroenterology, 2000
Bel okulu bel ağrılarının konservatif tedavisinde hastanın eğitimi ile bel ağrılarının önlenmesi ve rehabilitasyonunu amaçlayan terapötik bir yaklaşımdır.
Şehim Kutlay
doaj   +6 more sources

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

open access: yesFEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow   +12 more
wiley   +1 more source

Evaluating GenAI‐produced feedback on undergraduate bioscience essays against good higher education feedback practice

open access: yesFEBS Open Bio, EarlyView.
This pilot study investigates the potential of Generative AI to provide formative feedback to students. ChatGPT was prompted to provide feedback on Year 1 Bioscience essays, which were evaluated against established good feedback practices. GenAI‐authored feedback had useful elements, but was limited in scope. GenAI may have potential to provide instant,
Annabel Court   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy